Addex Therapeutics Ltd (ADXN) — Long-term Investment Intensity

Latest as of March 2026: 61.0%

Addex Therapeutics Ltd (ADXN) has a Long-term Investment Intensity of 61.0% as of March 2026. Long-term investments of CHF2.90 Million represent 61.0% of total assets of CHF4.76 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ADXN financial resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

61.0%
LT Investments / Total Assets

Long-term Investments

CHF2.90 Million
CHF

Total Assets

CHF4.76 Million
CHF

Country

Switzerland
SW

Addex Therapeutics Ltd Long-term Investment Intensity (2024–2025)

This chart shows how Addex Therapeutics Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 61.0%, reflecting long-term investments of CHF2.90 Million against total assets of CHF4.76 Million CHF. For the complete balance sheet picture, see ADXN total asset value.

Annual Long-term Investment Intensity for Addex Therapeutics Ltd (2024–2025)

The table below presents the year-by-year Long-term Investment Intensity for Addex Therapeutics Ltd from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Addex Therapeutics Ltd (ADXN) total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CHF) Total Assets Change (pp)
2025 65.0% CHF4.13 Million CHF6.36 Million ▼ -1.4 pp
2024 66.4% CHF7.09 Million CHF10.67 Million
pp = percentage points